1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Dermatitis, Atopic in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Cui, K; Feng, Y; Gu, L; Hu, J; Hu, Y; Huang, N; Li, G; Li, J; Li, W; Li, Y; Wang, X; Wu, W; Yu, J; Yue, C; Zeng, F; Zhao, F; Zhou, P | 1 |
Braathen, LR; Dummer, R; Levi-Schaffer, F; Menz, G; Plötz, S; Seitzer, U; Simon, D; Simon, HU; Straumann, A | 1 |
Al-Hassani, M; Billings, SD; Howard, KM; Ishii, S; Mousdicas, N; Perkins, SM; Shimizu, T; Travers, JB; Yi, Q; Zhang, Q | 1 |
Czarnetzki, B | 1 |
Hanahan, DJ; Humphrey, DM; Pinckard, RN | 1 |
Betz, S; Bruijnzeel, PL; Koenderman, L; Kuijper, PH; Rihs, S; Warringa, RA | 1 |
Bae, SJ; Hakugawa, J; Katayama, I; Tanaka, Y; Vinuesa, MA | 1 |
Archer, CB; Bradfield, JW; Brooks, J; Jenks, PJ; Kavanagh, GM | 1 |
Faccioli, LH; Kay, AB; Moqbel, R; Nourshargh, S; Sehmi, R; Williams, FM; Williams, TJ | 1 |
Becker, WM; Schade, U; Schaubschläger, WW; Schlaak, M; Zabel, P | 1 |
Bruijnzeel, P; Bruijnzeel-Koomen, C; Menz, G; Storz, E | 1 |
Bruijnzeel, PL; Koenderman, L | 1 |
Barnes, PJ; Chung, KF; Page, CP; Roberts, NM | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dermatitis, Atopic
Article | Year |
---|---|
Skin eosinophilia in patients with allergic and nonallergic asthma and atopic dermatitis.
Topics: Adult; Asthma; Dermatitis, Atopic; Eosinophilia; Female; Humans; Hypersensitivity; Male; Middle Aged; Platelet Activating Factor; Skin | 1992 |
Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects.
Topics: Acute Disease; Adult; Antigens; Dermatitis, Atopic; Female; Histamine; Humans; Lactones; Male; Plant Extracts; Platelet Activating Factor | 1988 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dermatitis, Atopic
Article | Year |
---|---|
WFDC12-overexpressing contributes to the development of atopic dermatitis via accelerating ALOX12/15 metabolism and PAF accumulation.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Dermatitis, Atopic; Dinitrofluorobenzene; Humans; Mice; Platelet Activating Factor; Proteins; Skin | 2023 |
Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
Topics: Asthma; Blood Proteins; Cell Degranulation; Dermatitis, Atopic; Drug Synergism; Eosinophil Granule Proteins; Eosinophilia; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypereosinophilic Syndrome; Interleukin-2; Interleukin-5; Platelet Activating Factor; Receptors, Interleukin-2; Ribonucleases; Syndrome | 2003 |
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
Topics: Animals; Calcium; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Hypersensitivity; Drug Synergism; Humans; Hypersensitivity, Delayed; Inflammation; Interleukin-10; Lipopolysaccharides; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Th1 Cells; Th2 Cells | 2005 |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.
Topics: Adolescent; Adult; Cells, Cultured; Chemotaxis, Leukocyte; Child; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Immunologic; Female; Humans; Leukotriene B4; Male; Monocytes; Platelet Activating Factor; Psoriasis; Urticaria | 1983 |
Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine.
Topics: Animals; Chemotaxis, Leukocyte; Dermatitis, Atopic; Female; Injections, Intradermal; Lysophosphatidylcholines; Male; Neutrophils; Platelet Activating Factor; Rabbits; Skin; Time Factors | 1982 |
Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
Topics: Adolescent; Adult; Cell Movement; Chemotaxis, Leukocyte; Complement C5a; Dermatitis, Atopic; Eosinophils; Female; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Factor 4 | 1993 |
[The inhibitory effect of LTB4 antagonist on eosinophil infiltration in cutaneous and gut late phase response in BALB/C mice sensitized with ovalubumin (OVA)].
Topics: Animals; Cell Movement; Dermatitis, Atopic; Eosinophils; Female; Immunization; Immunosuppressive Agents; Intestines; Leukotriene B4; Mice; Mice, Inbred BALB C; Ovalbumin; Phenylpropionates; Platelet Activating Factor; Skin; Thiazoles | 1997 |
Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects.
Topics: Case-Control Studies; Dermatitis, Atopic; Dose-Response Relationship, Immunologic; Histamine; Humans; Hypersensitivity; Microscopy, Electron; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Serum Albumin; Skin | 1999 |
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.
Topics: Albumins; Animals; Cell Movement; Complement C5a; Dermatitis, Atopic; Eosinophils; Female; Guinea Pigs; Indium Radioisotopes; Leukotriene B4; Platelet Activating Factor; Recombinant Proteins; Skin; Zymosan | 1991 |
Release of mediators from human gastric mucosa and blood in adverse reactions to benzoate.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aged; Asthma; Benzoates; Benzoic Acid; Dermatitis, Atopic; Endoscopy, Gastrointestinal; Female; Food Additives; Gastric Mucosa; Histamine; Histamine Release; Humans; Male; Middle Aged; Monocytes; Platelet Activating Factor; Urticaria | 1991 |
Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals.
Topics: Asthma; Dermatitis, Atopic; Eosinophils; Humans; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1989 |